| response to podophyllotoxin treatment of genital warts in relation to hiv-1 infection among patients in dar es salaam, tanzania. | forty-two tanzanian patients with genital warts were treated with 0.5% podophyllotoxin solution (wartec) for 3 days. thirteen patients (30.9%) were cured and a further 7 patients (16.7%) had more than 50% of lesions cleared at 6 weeks, while 19 patients were resistant to treatment. three patients had a recurrence of lesions after an initial response. thirty-three patients were tested for serological evidence of infection with human immunodeficiency virus (hiv) and 15 (45.5%) patients were shown ... | 1995 | 7779923 |
| impact of the change from an injectable to a fully oral regimen on patient adherence to ambulatory tuberculosis treatment in dar es salaam, tanzania. | to measure the impact on patient adherence to directly observed ambulatory tuberculosis treatment substituting an all-oral treatment regimen for a regimen containing streptomycin. | 1995 | 7579308 |
| a community trial of the impact of improved sexually transmitted disease treatment on the hiv epidemic in rural tanzania: 1. design. | to describe the rationale and design of a randomized trial of the impact of improved services for the treatment of sexually transmitted diseases (std) on the incidence of hiv infection in mwanza region, tanzania. | 1995 | 7576328 |
| kagera 1989 health survey: 1. human immunodeficiency virus seroprevalence in adolescents. | one thousand four hundred and fifty five adolescents were surveyed for human immunodeficiency virus (hiv) infection in an area experiencing aids epidemic. the study was done in order to estimate control measures. among the 1455 adolescents serosurveyed, 47 (3.2%) were hiv infected, of whom 30 (63.8%) were all aged 10-15 years old. the male/female ratio was 1:1. of all the adolescents examined 830 (57.1%) were attending school. among the selected potential risk factors namely non-school enrollmen ... | 1992 | 1505419 |
| examination of sera from human immunodeficiency virus type 1 (hiv-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of hiv-1 gp120 and for in vitro neutralizing activity. | sera from human immunodeficiency virus type 1 (hiv-1)-infected individuals from the united states and tanzania were examined for antibody reactivity to four synthetic peptides which corresponded to the principal neutralizing determinant from the v3 region of hiv-1 gp120. we observed that the majority of sera from both countries contained antibodies reactive with a v3 peptide whose sequence is based on that of the hiv-1 mn isolate. we were unable to establish a relationship between the presence o ... | 1992 | 1380094 |
| comparison of antibody reactivity to human immunodeficiency virus type 1 (hiv-1) gp160 epitopes in sera from hiv-1-infected individuals from tanzania and from the united states. | in this study, we compared sera from 159 human immunodeficiency virus type 1 (hiv-1)-infected individuals from tanzania and 103 infected individuals from the united states for antibodies reactive with 10 hiv-1 gp160 epitopes defined by synthetic peptides. our data indicate that the anti-gp160 antibody fine specificity differs between infected individuals from these two geographically diverse populations. for example, 50% of the tanzanian sera contained antibodies reactive with an immunodominant ... | 1992 | 1370844 |